التفاصيل البيبلوغرافية
| العنوان: |
Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial |
| المؤلفون: |
Griesinger, F., Curigliano, G., Thomas, M., Subbiah, V., Baik, C.S., Tan, D.S.W., Lee, D.H., Misch, D., Garralda, E., Kim, D.-W., van der Wekken, A.J., Gainor, J.F., Paz-Ares, L., Liu, S.V., Kalemkerian, G.P., Houvras, Y., Bowles, D.W., Mansfield, A.S., Lin, J.J., Smoljanovic, V., Rahman, A., Kong, S., Zalutskaya, A., Louie-Gao, M., Boral, A.L., Mazières, J. |
| المصدر: |
Annals of Oncology ; volume 33, issue 11, page 1168-1178 ; ISSN 0923-7534 |
| بيانات النشر: |
Elsevier BV |
| سنة النشر: |
2022 |
| المجموعة: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1016/j.annonc.2022.08.002 |
| الاتاحة: |
http://dx.doi.org/10.1016/j.annonc.2022.08.002
https://api.elsevier.com/content/article/PII:S0923753422038662?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753422038662?httpAccept=text/plain |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| رقم الانضمام: |
edsbas.21E84863 |
| قاعدة البيانات: |
BASE |